Company Filing History:
3 out of 5,089 
3 out of 170 
2 out of 223 
Years Active: 2019-2022
Title: Caroline Hemmer: Innovator in Virus-Like Particle Technology
Introduction
Caroline Hemmer is a distinguished inventor based in Colmar, France. She has made significant contributions to the field of biotechnology, particularly in the development of virus-like particles and their applications. With a total of three patents to her name, Hemmer's work has implications in various sectors, including pharmaceuticals and agriculture.
Latest Patents
Hemmer's latest patents include innovative technologies that utilize virus-like particles. One of her notable inventions is related to GFLV virus-like particles, which have potential uses in pharmaceutical, agro, and veterinary fields. Another significant patent involves novel fusion polypeptides derived from nepoviruses, which can be used to create virus-like particles that encapsulate molecules of interest. These advancements highlight her commitment to enhancing biotechnological applications.
Career Highlights
Throughout her career, Caroline Hemmer has worked with prestigious institutions such as the Centre National De La Recherche Scientifique and the Université de Strasbourg. Her research has focused on the intersection of virology and biotechnology, leading to groundbreaking innovations that address real-world challenges.
Collaborations
Hemmer has collaborated with notable colleagues in her field, including Christophe Ritzenthaler and Gérard Demangeat. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing her research.
Conclusion
Caroline Hemmer's contributions to the field of biotechnology through her patents and collaborations underscore her role as a leading innovator. Her work with virus-like particles continues to pave the way for advancements in various applications, making a significant impact in her field.